Health Care · Services-Nursing & Personal Care Facilities · NYSE · CIK 1332349 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $14.62Day −1.62%Mkt cap $3.5B1Y +89.4%Off 52W high −14.4%Vol (1Y) 40.1%
Daily closing price, split-adjusted to the current basis; 3y shown of 5,200 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Price impliesNEVER-OBSERVED · 107.2% growth |
| Short interest15.7% of sh out |
| Days to cover7.6d |
| 13F net flow (QoQ)+1.06% |
| Top-10 13F concentration44.1% |
| Next report (est.)2026-08-06 |
Fair value, confidence and the reverse-DCF grade are the MATERIALIZED daily snapshot (the same columns the screener serves), not a live model run. Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$3.15B |
| Earnings (TTM)-$204.6M |
| Net margin−8.2% |
| ROIC0.3% |
| Total debt / EBITDA11.18× |
| Sales growth 3Y4.2% |
| YTD+35.5% |
| 1Y+89.4% |
| 3Y+315.3% |
| 5Y+94.4% |
| 10Y−20.5% |
| Since incept. (ann.)−2.9% |
Total return through 2026-07-30 · series begins 2005-11-22. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)40.1% |
| Ann. volatility (3Y)45.7% |
| Sharpe (1Y)1.83 |
| Sharpe (3Y)1.27 |
| Max drawdown (1Y)−29.2% |
| Max drawdown (3Y)−43.6% |
| Beta (3Y vs SPY)0.43 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BlackRock, Inc. | 22.7M | $311M | 9.55% | −27.0% |
| WCM INVESTMENT MANAGEMENT, LLC | 12.8M | $172M | 5.39% | new |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 11.6M | $159M | 4.89% | +0.0% |
| ANTIPODES PARTNERS Ltd | 11.4M | $156M | 4.80% | −0.2% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 10.4M | $142M | 4.37% | new |
| VANGUARD CAPITAL MANAGEMENT LLC | 10.1M | $138M | 4.25% | new |
| WELLINGTON MANAGEMENT GROUP LLP | 8.8M | $121M | 3.71% | −13.1% |
| CARRONADE CAPITAL MANAGEMENT, LP | 8.6M | $117M | 3.61% | +16.8% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. Institutional 13F holdings sum to 107.0% of shares outstanding. Readings above 100% reflect securities-lending double counting: shares on loan to short sellers are reported long by both the lending institution and the one that bought them. FINRA short interest of 37,833,539 shares (settlement 2026-04-30) accounts for the excess.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-06 | −$0.03 | — | $764.9M | −6.0% |
| 2025-12-31 | 2026-02-18 | — | — | $754.1M | −3.4% |
| 2025-09-30 | 2025-11-06 | −$0.48 | — | $813.2M | +3.7% |
| 2025-06-30 | 2025-08-06 | −$0.18 | — | $812.9M | +4.6% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-06 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
Health Care Resident Service 95% · Reimbursement Costs Managed Communities 4% · Management Service 0%
product & service · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
